You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0119 What Intrinsic and Extrinsic Factors Affect the Developement of Anti-Drug Antibody to Innovator Infliximab and its Biosimilar CT-P13 in Rheumatoid Arthritis and Ankylosing Spondylitis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
FRI0119 What Intrinsic and Extrinsic Factors Affect the Developement of Anti-Drug Antibody to Innovator Infliximab and its Biosimilar CT-P13 in Rheumatoid Arthritis and Ankylosing Spondylitis

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20152801
Jul 20155205
Aug 20153601
Sep 20153703
Oct 2015803
Nov 20153400
Dec 20151203
Jan 20163004
Feb 20162504
Mar 20161600
Apr 20161401
May 2016701
Jun 20162201
Jul 20161301
Aug 20161503
Sep 201611027
Oct 20161401
Nov 20161301
Dec 2016400
Jan 2017500
Feb 20171000
Mar 20171001
Apr 2017801
May 20171600
Jun 20171102
Jul 20171002
Aug 20171400
Sep 20171200
Oct 20171801
Nov 20171000
Dec 2017600
Jan 20181200
Feb 2018400
Mar 20181601
Apr 20181400
May 20182201
Jun 20181401
Jul 20181000
Aug 2018601
Sep 2018400
Oct 20182600
Nov 20182201
Dec 20181600
Jan 2019601
Feb 2019400
Mar 2019500
Apr 2019800
May 2019800
Jun 2019802
Jul 20191300
Sep 2019700
Oct 20192404
Nov 2019800
Dec 2019300
Jan 20201000
Feb 2020501
Mar 20201400
Apr 2020200
Jun 2020500
Jul 20201000
Aug 20201001
Sep 20202100
Oct 20201101
Nov 2020600
Dec 2020201
Jan 2021200
Feb 2021200
Mar 2021200
Apr 2021100
Jun 2021500
Jul 2021201
Aug 2021100
Sep 2021100
Oct 20211300
Nov 20211401
Dec 20211400
Jan 20221700
Feb 20221001
Mar 2022301
Apr 2022300
May 20221000
Jun 2022700
Jul 20221500
Aug 20222300
Sep 2022900
Oct 20221000
Nov 2022800
Dec 20221300
Jan 20231200
Feb 20231001
Mar 2023500
Apr 2023500
May 20231400
Jun 20231000
Jul 2023400
Aug 2023900
Sep 2023800
Oct 2023400
Nov 2023200
Dec 20231900
Jan 2024500
Feb 20241000
Mar 2024700
Total1186088